Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04159896
Title ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

prostate cancer

Therapies

CEP-11981 + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.